ASRT - Assertio Holdings Inc
11.95
-0.120 -1.004%
Share volume: 15,017
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$12.07
-0.12
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-06-2024 | 08-07-2024 | 11-12-2024 | 03-12-2025 | 05-12-2025 | 11-10-2025 | |
| Total revenue | 32.448 M | 31.126 M | 29.204 M | 32.183 M | 26.488 M | 49.459 M | |
| Cost of revenue | 11.177 M | 8.889 M | 7.550 M | 11.611 M | 7.786 M | 13.654 M | |
| Gross profit | 21.271 M | 22.237 M | 21.654 M | 20.572 M | 18.702 M | 35.805 M | |
| 4.54% | -2.62% | -5.00% | -9.09% | 91.45% | |||
| Operating expenses | 19.257 M | 19.183 M | 17.731 M | 22.702 M | 22.413 M | 17.309 M | |
| Selling general and admin | 18.524 M | 18.385 M | 16.726 M | 21.416 M | 21.975 M | 16.930 M | |
| Research and development | 733.000 K | 798.000 K | 1.005 M | 1.286 M | 438.000 K | 379.000 K | |
| Total expenses | 25.608 M | 25.854 M | 24.702 M | 34.046 M | 31.935 M | 24.327 M | |
| 0.96% | -4.46% | 37.83% | -6.20% | -23.82% | |||
| Operating income | -4.337 M | -3.617 M | -3.048 M | -13.474 M | -13.233 M | 11.478 M | |
| Ebit | -3.621 M | -3.609 M | -3.003 M | -11.478 M | -13.251 M | 11.504 M | |
| Pretax income | -4.378 M | -3.525 M | -2.877 M | -10.749 M | -13.296 M | 11.398 M | |
| -19.48% | -18.38% | 273.62% | 23.70% | -185.73% | |||
| Income tax | 132.000 K | 149.000 K | 44.000 K | -273.000 K | 245.000 K | -47.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -4.510 M | -3.674 M | -2.921 M | -10.476 M | -13.541 M | 11.445 M | |
| 18.54% | 20.50% | -258.64% | -29.26% | 184.52% |